- Home
- BLBD vs NVCR Comparison
BLBD vs NVCR Comparison
Compare BLBD & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLBD | NVCR |
|---|---|---|
| Founded | 1927 | 2000 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | BLBD | NVCR |
|---|---|---|
| Price | $50.74 | $13.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $64.60 | $28.42 |
| AVG Volume (30 Days) | 349.3K | ★ 1.8M |
| Earning Date | 02-04-2026 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.79 | N/A |
| EPS | ★ 3.88 | N/A |
| Revenue | ★ $1,480,099,000.00 | $642,269,000.00 |
| Revenue This Year | $4.86 | $9.75 |
| Revenue Next Year | $3.41 | $5.62 |
| P/E Ratio | $13.08 | ★ N/A |
| Revenue Growth | 9.87 | ★ 11.17 |
| 52 Week Low | $30.04 | $10.70 |
| 52 Week High | $61.95 | $32.06 |
Technical Indicators
Market Signals| Indicator | BLBD | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 45.89 | 59.44 |
| Support Level | $51.03 | $12.30 |
| Resistance Level | $52.89 | $13.97 |
| Average True Range (ATR) | 1.44 | 0.55 |
| MACD | 0.11 | 0.09 |
| Stochastic Oscillator | 38.06 | 77.21 |
Price Performance
Historical ComparisonAbout BLBD Blue Bird Corporation
Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.